AR and prostate carcinoma: Consistent with these observations, treatment of LNCaP human prostate cancer cells, which express abundant levels of AR (as compared with normal proliferating PrECs) [33], with 10 nM concentration of DHT also increased the levels of POP3 mRNA (Figure 2D).